Skip to main content
Top
Published in: Annals of Surgical Oncology 7/2014

01-07-2014 | Healthcare Policy and Outcomes

Differences in Perioperative Care at Low- and High-Mortality Hospitals with Cancer Surgery

Authors: Sha’Shonda L. Revels, MD, MS, MA, Sandra L. Wong, MD, MS, Mousumi Banerjee, PhD, Huiying Yin, MS, John D. Birkmeyer, MD

Published in: Annals of Surgical Oncology | Issue 7/2014

Login to get access

Abstract

Objective

To evaluate adherence to perioperative processes of care associated with major cancer resections.

Background

Mortality rates associated with major cancer resections vary across hospitals. Because mechanisms underlying such variations are not well-established, we studied adherence to perioperative care processes.

Methods

There were 1,279 hospitals participating in the National Cancer DataBase (2005–2006) ranked on a composite measure of mortality for bladder, colon, esophagus, stomach, lung, and pancreas cancer operations. We sampled hospitals from among those with the lowest and highest mortality rates, with 19 low-mortality hospitals [(LMHs), risk-adjusted mortality rate of 2.84 %] and 30 high-mortality hospitals [(HMHs), risk-adjusted mortality rate of 7.37 %]. We then conducted onsite chart reviews. Using logistic regression, we examined differences in perioperative care, adjusting for patient and tumor characteristics.

Results

Compared to LMHs, HMHs were less likely to use prophylaxis against venous thromboembolism, either preoperative or postoperatively [adjusted relative risk (aRR) 0.74, 95 % CI 0.50–0.92 and aRR 0.80, 95 % CI 0.56–0.93, respectively]. The two hospital groups were indistinguishable with respect to processes aimed at preventing surgical site infections, such as the use of antibiotics prior to incision (aRR, 0.99, 95 % CI 0.90–1.04), and processes intended to prevent cardiac events, including the use of β-blockers (1.00, 95 % CI 0.81–1.14). HMHs were significantly less likely to use epidurals (aRR, 0.57, 95 % CI 0.32–0.93).

Conclusions

HMHs and LMHs differ in several aspects of perioperative care. These areas may represent opportunities for improving cancer surgery quality at hospitals with high mortality.
Literature
1.
2.
go back to reference Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery. 1999;125:250–6.PubMedCrossRef Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM, Warshaw AL, Fisher ES. Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery. 1999;125:250–6.PubMedCrossRef
3.
go back to reference Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011;49:1076–81.PubMedCrossRef Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011;49:1076–81.PubMedCrossRef
5.
go back to reference Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747–51.PubMedCrossRef Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998;280:1747–51.PubMedCrossRef
6.
go back to reference Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S51–61.PubMedCrossRef Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S51–61.PubMedCrossRef
8.
go back to reference Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.PubMedCrossRef Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.PubMedCrossRef
9.
go back to reference Zingg U, Smithers BM, Gotley DC, et al. Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol. 2011;18:1460–8.PubMedCrossRef Zingg U, Smithers BM, Gotley DC, et al. Factors associated with postoperative pulmonary morbidity after esophagectomy for cancer. Ann Surg Oncol. 2011;18:1460–8.PubMedCrossRef
10.
go back to reference Warschkow R, Steffen T, Luthi A, et al. Epidural analgesia in open resection of colorectal cancer: is there a clinical benefit? A retrospective study on 1,470 patients. J Gastrointest Surg. 2011;15:1386–93.PubMedCrossRef Warschkow R, Steffen T, Luthi A, et al. Epidural analgesia in open resection of colorectal cancer: is there a clinical benefit? A retrospective study on 1,470 patients. J Gastrointest Surg. 2011;15:1386–93.PubMedCrossRef
11.
go back to reference Popping DM, Elia N, Marret E, Remy C, Tramer MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg Chic. 2008;143:990–1000.CrossRef Popping DM, Elia N, Marret E, Remy C, Tramer MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg Chic. 2008;143:990–1000.CrossRef
13.
go back to reference Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD. Empirically derived composite measures of surgical performance. Med Care. 2009;47:226–33.PubMedCrossRef Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD. Empirically derived composite measures of surgical performance. Med Care. 2009;47:226–33.PubMedCrossRef
14.
go back to reference Dimick JB, Staiger DO, Baser O, Birkmeyer JD. Composite measures for predicting surgical mortality in the hospital. Health Aff. 2009;28:1189–98.CrossRef Dimick JB, Staiger DO, Baser O, Birkmeyer JD. Composite measures for predicting surgical mortality in the hospital. Health Aff. 2009;28:1189–98.CrossRef
15.
go back to reference Dimick JB, Ghaferi AA, Osborne NH, Ko CY, Hall BL. Reliability adjustment for reporting hospital outcomes with surgery. Ann Surg. 2012;255:703–07.PubMedCrossRef Dimick JB, Ghaferi AA, Osborne NH, Ko CY, Hall BL. Reliability adjustment for reporting hospital outcomes with surgery. Ann Surg. 2012;255:703–07.PubMedCrossRef
16.
go back to reference Waljee JF, Windisch S, Finks JF, Wong SL, Birkmeyer JD. Classifying cause of death after cancer surgery. Surg Innov. 2006;13:274–9.PubMedCrossRef Waljee JF, Windisch S, Finks JF, Wong SL, Birkmeyer JD. Classifying cause of death after cancer surgery. Surg Innov. 2006;13:274–9.PubMedCrossRef
17.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.PubMedCrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.PubMedCrossRef
18.
go back to reference Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1.PubMedCrossRef Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1.PubMedCrossRef
19.
go back to reference Daley J, Forbes MG, Young GJ, et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surgeons. 1997;185:341–51. Daley J, Forbes MG, Young GJ, et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surgeons. 1997;185:341–51.
20.
go back to reference Gibbs J, Clark K, Khuri S, Henderson W, Hur K, Daley J. Validating risk-adjusted surgical outcomes: chart review of process of care. Int J Qual Health Care. 2001;13:187–196.PubMedCrossRef Gibbs J, Clark K, Khuri S, Henderson W, Hur K, Daley J. Validating risk-adjusted surgical outcomes: chart review of process of care. Int J Qual Health Care. 2001;13:187–196.PubMedCrossRef
21.
go back to reference Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S–400S. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S–400S.
22.
go back to reference Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol. 2007;14:929–36.PubMedCrossRef Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol. 2007;14:929–36.PubMedCrossRef
23.
go back to reference Kwon S, Meissner M, Symons R, et al. Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg. 2011;213:596–603e1. Kwon S, Meissner M, Symons R, et al. Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg. 2011;213:596–603e1.
24.
go back to reference Amin AN, Lin J, Johnson BH, Schulman KL. Clinical and economic outcomes with appropriate or partial prophylaxis. Thromb Res. 2010;125:513–17.PubMedCrossRef Amin AN, Lin J, Johnson BH, Schulman KL. Clinical and economic outcomes with appropriate or partial prophylaxis. Thromb Res. 2010;125:513–17.PubMedCrossRef
25.
go back to reference Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011;112:1392–402.PubMedCrossRef Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg. 2011;112:1392–402.PubMedCrossRef
26.
go back to reference Rigg JR, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276–282.PubMedCrossRef Rigg JR, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276–282.PubMedCrossRef
27.
go back to reference Marret E, Remy C, Bonnet F. Meta-analysis of epidural analgesia versus parenteral opioid analgesia after colorectal surgery. Br J Surg. 2007;94:665–73.PubMedCrossRef Marret E, Remy C, Bonnet F. Meta-analysis of epidural analgesia versus parenteral opioid analgesia after colorectal surgery. Br J Surg. 2007;94:665–73.PubMedCrossRef
28.
go back to reference Bredtmann RD, Kniesel B, Herden HN, Teichmann W. The effect of continuous thoracic peridural anesthesia on the pulmonary function of patients undergoing colon surgery. Results of a randomized study of 116 patients. Reg Anaesth. 1991;14:2–8.PubMed Bredtmann RD, Kniesel B, Herden HN, Teichmann W. The effect of continuous thoracic peridural anesthesia on the pulmonary function of patients undergoing colon surgery. Results of a randomized study of 116 patients. Reg Anaesth. 1991;14:2–8.PubMed
29.
go back to reference Halabi WJ, Jafari MD, Nguyen VQ, et al. A nationwide analysis of the use and outcomes of epidural analgesia in open colorectal surgery. J Gastrointest Surg. 2013;17:1130–7.PubMedCrossRef Halabi WJ, Jafari MD, Nguyen VQ, et al. A nationwide analysis of the use and outcomes of epidural analgesia in open colorectal surgery. J Gastrointest Surg. 2013;17:1130–7.PubMedCrossRef
30.
go back to reference Campbell DA Jr., Henderson WG, Englesbe MJ, et al. Surgical site infection prevention: the importance of operative duration and blood transfusion: results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg. 2008;207:810–20.PubMedCrossRef Campbell DA Jr., Henderson WG, Englesbe MJ, et al. Surgical site infection prevention: the importance of operative duration and blood transfusion: results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg. 2008;207:810–20.PubMedCrossRef
31.
go back to reference Ingraham AM, Cohen ME, Bilimoria KY, et al. Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211:705–14.PubMedCrossRef Ingraham AM, Cohen ME, Bilimoria KY, et al. Association of surgical care improvement project infection-related process measure compliance with risk-adjusted outcomes: implications for quality measurement. J Am Coll Surg. 2010;211:705–14.PubMedCrossRef
32.
go back to reference Hawn MT, Richman JS, Vick CC, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013;148:649–57.PubMedCrossRef Hawn MT, Richman JS, Vick CC, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg. 2013;148:649–57.PubMedCrossRef
33.
go back to reference Lindenauer PK, Fitzgerald J, Hoople N, Benjamin EM. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med. 2004;164:762–6.PubMedCrossRef Lindenauer PK, Fitzgerald J, Hoople N, Benjamin EM. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med. 2004;164:762–6.PubMedCrossRef
34.
go back to reference Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008;372:1962–76.PubMedCrossRef Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet. 2008;372:1962–76.PubMedCrossRef
35.
go back to reference London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013;309:1704–13.PubMedCrossRef London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013;309:1704–13.PubMedCrossRef
36.
go back to reference Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138:721–6.PubMedCrossRef Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138:721–6.PubMedCrossRef
Metadata
Title
Differences in Perioperative Care at Low- and High-Mortality Hospitals with Cancer Surgery
Authors
Sha’Shonda L. Revels, MD, MS, MA
Sandra L. Wong, MD, MS
Mousumi Banerjee, PhD
Huiying Yin, MS
John D. Birkmeyer, MD
Publication date
01-07-2014
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 7/2014
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-3692-8

Other articles of this Issue 7/2014

Annals of Surgical Oncology 7/2014 Go to the issue